Gopi K Kolluru

Title: Gopi K Kolluru: Innovator in Cardiovascular Treatment

Introduction

Gopi K Kolluru is a notable inventor based in Shreveport, Louisiana. He has made significant contributions to the field of medicine, particularly in the treatment of cardiovascular diseases related to methamphetamine use. His innovative approach has the potential to improve patient outcomes and advance medical science.

Latest Patents

Gopi K Kolluru holds a patent for a method of treating or preventing methamphetamine-related endothelial dysfunction. This patent outlines a pharmacologic composition that includes a hydrogen sulfide (HS) donor. The HS donor may consist of various compounds, including sodium sulfide, diallyl trisulfide, and sugammadex. The method involves administering an effective dose of the composition to patients, with dosages ranging from 0.5 mg/kg to 10.0 mg/kg. This innovative treatment could provide new hope for patients suffering from cardiovascular issues linked to methamphetamine use. He has 1 patent to his name.

Career Highlights

Gopi K Kolluru is affiliated with Louisiana State University and Agricultural & Mechanical College, where he conducts research and develops new therapeutic methods. His work is characterized by a commitment to addressing critical health issues and improving treatment options for patients.

Collaborations

Gopi collaborates with Christopher Kevil, who is also involved in research related to cardiovascular health. Their partnership exemplifies the importance of teamwork in advancing medical innovations.

Conclusion

Gopi K Kolluru's contributions to the field of cardiovascular treatment highlight the impact of innovative thinking in medicine. His work not only addresses pressing health concerns but also paves the way for future advancements in therapeutic approaches.